Mutation Abnormality

general

Centers

Active Trials

$12.6B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Loss of Heterozygosity	47	—

Top Centers for Mutation Abnormality(47)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	$911M	—
2	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	$754M	—
3	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive	—	$737M	—
4	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	$655M	—
5	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive	—	$604M	—
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive	—	$517M	—
7	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive	—	$505M	—
8	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive	—	$484M	—
9	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	$472M	—
10	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	$454M	—
11	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	$452M	—
12	Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY	—	$386M	—
13	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	$375M	—
14	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	$370M	—
15	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive	—	$368M	—
16	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	$347M	—
17	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	$319M	—
18	Moffitt Cancer CenterTampa, FL NCI Comprehensive	—	$296M	—
19	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	$276M	—
20	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	$262M	—
21	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive	—	$227M	—
22	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	$222M	—
23	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	$216M	—
24	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	$194M	—
25	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	$186M	—
26	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	$181M	—
27	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive	—	$163M	—
28	UMass Memorial Health Cancer CenterWorcester, MA	—	$155M	—
29	Cleveland Clinic Cancer CenterCleveland, OH	—	$150M	—
30	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	$143M	—
31	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	$134M	—
32	University of Illinois Cancer CenterChicago, IL	—	$122M	—
33	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	$116M	—
34	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	$110M	—
35	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	$106M	—
36	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	$103M	—
37	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	$94M	—
38	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	$83M	—
39	Cancer Center at IllinoisUrbana, IL	—	$81M	—
40	Penn State Cancer InstituteHershey, PA	—	$73M	—
41	University of Cincinnati Cancer CenterCincinnati, OH	—	$71M	—
42	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	$53M	—
43	The University of Vermont Cancer CenterBurlington, VT	—	$43M	—
44	University of Texas Medical Branch Cancer CenterGalveston, TX	—	$15M	—
45	Loma Linda University Cancer CenterLoma Linda, CA	—	$10M	—
46	Tampa General Hospital Cancer InstituteTampa, FL	—	—	—
47	Louisiana Cancer Research CenterNew Orleans, LA	—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →